| Stage | KMX | % of rev | GKOS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.9B | 100.00% | $211M | 100.00% | KMX ×37.33 |
| Gross profit | $799M | 10.15% | $180M | 85.23% | GKOS +75.1pp |
| Operating income | $101M | 1.28% | $828,000 | 0.39% | KMX +0.9pp |
| Pre-tax income | $223M | 2.83% | $2M | 1.10% | KMX +1.7pp |
| Net income | $165M | 2.10% | $2M | 0.96% | KMX +1.1pp |
| Stage | KMX | GKOS | Gap · A − B |
|---|---|---|---|
| Revenue | $7.9B100.00% | $211M100.00% | KMX ×37.33 |
| Gross profit | 10.15%$799M | 85.23%$180M | GKOS +75.1pp |
| Operating income | 1.28%$101M | 0.39%$828,000 | KMX +0.9pp |
| Pre-tax income | 2.83%$223M | 1.10%$2M | KMX +1.7pp |
| Net income |
| 2.10%$165M |
| 0.96%$2M |
| KMX +1.1pp |
No disclosed counterparties: GKOS.
None